Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INVERT: INRT vs ENI in Head and Neck Cancer
NCT06477692Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2024
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Solitary Elective Volume Recurrence at 2 years. Started Nov 2024; status: recruiting.
02
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06477692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06477692.